Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia – a retrospective cohort study on the role of bacteriuria
European Journal of Clinical Microbiology & Infectious Diseases · 2024
DOI: 10.1007/s10096-024-04850-7 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Oskar Bergenman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Kalmar Regional Hospital, Kalmar, Sweden. oskar.bergenman@gmail.com. Hauptthemen laut MEDLINE: Staphylococcal Infections, Bacteremia, Staphylococcus aureus, Bacteriuria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lund University.
Abstract (Originalsprache)
Purpose
S. aureus bacteremia (SAB) is a common and severe infection with high mortality and morbidity. The clinical relevance of the finding of concurrent S. aureus bacteriuria (SABU) is debated. The goal of this study was to analyze whether a concurrent SABU is associated with complicated SAB, infective endocarditis (IE) and mortality.
Methods
We conducted a retrospective cohort study, reviewing medical charts of all episodes of SAB in patients > 18 years in the region of Skåne, Sweden, between 1st of January and 31st of June 2020. Episodes where a concurrent urine culture was performed were included for analysis. An episode was considered as complicated SAB if there was either attributable mortality, recurrent infection, embolic stroke, or occurrence of a complicated focus of infection.
Results
During the study period, there were 279 episodes of SAB. 154 episodes met the eligibility criteria, of whom 37 (24%) had concurrent SABU. In 78 episodes (51%), the patients had a complicated SAB. There was a significantly lower proportion of complicated SAB for episodes with concurrent SABU (32%), compared to episodes without concurrent SABU (56%), p-value 0.014. Moreover, in the cohort there were 11 episodes (7.1%) of IE and a 30 days mortality rate of 16%, with no difference between the groups with or without SABU.
Conclusions
There is an association between concurrent SABU and a decreased risk for complicated SAB among patients with SAB. This study found no significant association between SABU and neither IE nor mortality for patients with SAB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kalmar Regional Hospital, Kalmar, Sweden. oskar.bergenman@gmail.com.
- Division of Infection Medicine, Department of Clinical Sciences, Lund University, BMC B14 SE-221 84, Lund, Sweden. oskar.bergenman@gmail.com.
- Clinical Microbiology, Office for Medical Services, Infection Prevention and Control, Region Skåne, Lund, Sweden.
- Division of Medical Microbiology, Department of Laboratory Medicine Lund, Lund University, Lund, Sweden.
- Division of Infection Medicine, Department of Clinical Sciences, Lund University, BMC B14 SE-221 84, Lund, Sweden. magnus.rasmussen@med.lu.se.
- Department of Infectious Diseases, Skåne University Hospital, Lund, Sweden. magnus.rasmussen@med.lu.se.
Förderung
- Lund University
Zitieren
APA
Bergenman, O., Nilson, B., & Rasmussen, M. (2024). Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia – a retrospective cohort study on the role of bacteriuria. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04850-7
Vancouver
Bergenman O, Nilson B, Rasmussen M. Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia – a retrospective cohort study on the role of bacteriuria. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04850-7
BibTeX
@article{Bergenman2024,
author = {Bergenman, Oskar and Nilson, Bo and Rasmussen, Magnus},
title = {Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia – a retrospective cohort study on the role of bacteriuria},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
doi = {10.1007/s10096-024-04850-7}
}
EUVIMED